Literature DB >> 33961914

A deep learning-based auto-segmentation system for organs-at-risk on whole-body computed tomography images for radiation therapy.

Xuming Chen1, Shanlin Sun2, Narisu Bai3, Kun Han3, Qianqian Liu1, Shengyu Yao1, Hao Tang4, Chupeng Zhang3, Zhipeng Lu3, Qian Huang1, Guoqi Zhao1, Yi Xu1, Tingfeng Chen1, Xiaohui Xie5, Yong Liu6.   

Abstract

BACKGROUND AND
PURPOSE: Delineating organs at risk (OARs) on computed tomography (CT) images is an essential step in radiation therapy; however, it is notoriously time-consuming and prone to inter-observer variation. Herein, we report a deep learning-based automatic segmentation (AS) algorithm (WBNet) that can accurately and efficiently delineate all major OARs in the entire body directly on CT scans.
MATERIALS AND METHODS: We collected 755 CT scans of the head and neck, thorax, abdomen, and pelvis and manually delineated 50 OARs on the CT images. The CT images with contours were split into training and test sets consisting of 505 and 250 cases, respectively, to develop and validate WBNet. The volumetric Dice similarity coefficient (DSC) and 95th-percentile Hausdorff distance (95% HD) were calculated to evaluate delineation quality for each OAR. We compared the performance of WBNet with three AS algorithms: one commercial multi-atlas-based automatic segmentation (ABAS) software, and two deep learning-based AS algorithms, namely, AnatomyNet and nnU-Net. We have also evaluated the time saving and dose accuracy of WBNet.
RESULTS: WBNet achieved average DSCs of 0.84 and 0.81 on in-house and public datasets, respectively, which outperformed ABAS, AnatomyNet, and nnU-Net. WBNet could reduce the delineation time significantly and perform well in treatment planning, with clinically acceptable dose differences compared with those in manual delineation.
CONCLUSION: This study shows the feasibility and benefits of using WBNet in clinical practice.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Automatic segmentation; Deep learning; Organs at risk

Year:  2021        PMID: 33961914     DOI: 10.1016/j.radonc.2021.04.019

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  General and custom deep learning autosegmentation models for organs in head and neck, abdomen, and male pelvis.

Authors:  Asma Amjad; Jiaofeng Xu; Dan Thill; Colleen Lawton; William Hall; Musaddiq J Awan; Monica Shukla; Beth A Erickson; X Allen Li
Journal:  Med Phys       Date:  2022-02-07       Impact factor: 4.071

2.  Real-world analysis of manual editing of deep learning contouring in the thorax region.

Authors:  Femke Vaassen; Djamal Boukerroui; Padraig Looney; Richard Canters; Karolien Verhoeven; Stephanie Peeters; Indra Lubken; Jolein Mannens; Mark J Gooding; Wouter van Elmpt
Journal:  Phys Imaging Radiat Oncol       Date:  2022-05-14

3.  Impact of Using Unedited CT-Based DIR-Propagated Autocontours on Online ART for Pancreatic SBRT.

Authors:  Alba Magallon-Baro; Maaike T W Milder; Patrick V Granton; Wilhelm den Toom; Joost J Nuyttens; Mischa S Hoogeman
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

4.  Validation of an established deep learning auto-segmentation tool for cardiac substructures in 4D radiotherapy planning scans.

Authors:  Gerard M Walls; Valentina Giacometti; Aditya Apte; Maria Thor; Conor McCann; Gerard G Hanna; John O'Connor; Joseph O Deasy; Alan R Hounsell; Karl T Butterworth; Aidan J Cole; Suneil Jain; Conor K McGarry
Journal:  Phys Imaging Radiat Oncol       Date:  2022-07-26

5.  Auto-segmentation for total marrow irradiation.

Authors:  William Tyler Watkins; Kun Qing; Chunhui Han; Susanta Hui; An Liu
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

6.  A deep learning-based self-adapting ensemble method for segmentation in gynecological brachytherapy.

Authors:  Zhen Li; Qingyuan Zhu; Lihua Zhang; Xiaojing Yang; Zhaobin Li; Jie Fu
Journal:  Radiat Oncol       Date:  2022-09-05       Impact factor: 4.309

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.